Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
CyberArk price target raised to $85 from $80 at DA Davidson » 09:16
05/14/20
05/14
09:16
05/14/20
09:16
CYBR

CyberArk

$96.80 /

-12.88 (-11.74%)

DA Davidson analyst…

DA Davidson analyst Andrew Nowinski raised the firm's price target on CyberArk to $85 from $80, adjusting his valuation model to enterprise value at 4.5-times his expected 2021 sales. The analyst is cutting his FY20 and FY21 EPS views to $1.53 from $2.08 and to $1.94 from $2.33 respectively while keeping a Neutral rating on the shares however to reflect the limited visibility on deal closing trends and the lower than expected Q2 guidance ranges.

ShowHide Related Items >><<
CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

05/14/20 Guggenheim
CyberArk price target lowered to $115 from $134 at Guggenheim
05/14/20 UBS
CyberArk price target lowered to $94 from $104 at UBS
05/13/20 William Blair
William Blair keeps Outperform on CyberArk following 'solid' quarter
04/08/20 DA Davidson
DA Davidson says Proofpoint, SailPoint have strongest pipelines in sector
CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

Recommendations
CyberArk price target lowered to $115 from $134 at Guggenheim » 08:57
05/14/20
05/14
08:57
05/14/20
08:57
CYBR

CyberArk

$96.80 /

-12.88 (-11.74%)

Guggenheim analyst Imtiaz…

Guggenheim analyst Imtiaz Koujalgi lowered the firm's price target on CyberArk to $115 from $134 after the company reported revenues that were near the lower end of its guidance and in line with consensus expectations. License revenues came in below consensus as deals were downsized and pushed out and revenue guidance for Q2 lagged the consensus view while the company withdrew its FY20 guidance, noted Koujalgi. The analyst keeps a Buy rating on the shares, stating that the company's Q2 outlook "seems reasonably conservative" and adding that the company's Idaptive acquisition will increase the recurring revenue mix.

ShowHide Related Items >><<
CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

05/14/20 UBS
CyberArk price target lowered to $94 from $104 at UBS
05/13/20 William Blair
William Blair keeps Outperform on CyberArk following 'solid' quarter
04/08/20 DA Davidson
DA Davidson says Proofpoint, SailPoint have strongest pipelines in sector
03/24/20 Goldman Sachs
Goldman Sachs starts Rapid7, Tenable Holdings at Buy, SailPoint at Sell
CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

Recommendations
CyberArk price target lowered to $94 from $104 at UBS » 06:23
05/14/20
05/14
06:23
05/14/20
06:23
CYBR

CyberArk

$96.80 /

-12.88 (-11.74%)

UBS analyst Fatima…

UBS analyst Fatima Boolani lowered the firm's price target on CyberArk to $94 from $104 and keeps a Neutral rating on the shares after its Q1 results. The quarter reflected challenged new business activity as new logo adds slowed and installed base reliance ramped, the analyst tells investors in a research note. Boolani adds that the wide Q2 guidance by the management was driven by "increasing spending uncertainty that risks deal cancellation, deferral, and downsizing."

ShowHide Related Items >><<
CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

05/13/20 William Blair
William Blair keeps Outperform on CyberArk following 'solid' quarter
04/08/20 DA Davidson
DA Davidson says Proofpoint, SailPoint have strongest pipelines in sector
03/24/20 Goldman Sachs
Goldman Sachs starts Rapid7, Tenable Holdings at Buy, SailPoint at Sell
03/24/20 Goldman Sachs
CyberArk initiated with a Neutral at Goldman Sachs
CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

Earnings
CyberArk sees Q2 EPS 17c-35c, consensus 36c » 06:22
05/14/20
05/14
06:22
05/14/20
06:22
CYBR

CyberArk

$96.80 /

-12.88 (-11.74%)

As part of its Q1…

As part of its Q1 earnings announcement yesterday, CyberArk also guided Q2 revenue $95M-$105M, consensus $107.02M.

ShowHide Related Items >><<
CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

05/13/20 William Blair
William Blair keeps Outperform on CyberArk following 'solid' quarter
04/08/20 DA Davidson
DA Davidson says Proofpoint, SailPoint have strongest pipelines in sector
03/24/20 Goldman Sachs
Goldman Sachs starts Rapid7, Tenable Holdings at Buy, SailPoint at Sell
03/24/20 Goldman Sachs
CyberArk initiated with a Neutral at Goldman Sachs
CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

CYBR CyberArk
$96.80 /

-12.88 (-11.74%)

Recommendations
William Blair keeps Outperform on CyberArk following 'solid' quarter » 14:34
05/13/20
05/13
14:34
05/13/20
14:34
CYBR

CyberArk

$97.00 /

-12.68 (-11.56%)

William Blair analyst…

William Blair analyst Jonathan Ho maintains an Outperform rating on CyberArk following the company's "solid" Q1 results, despite the impact of COVID-19. The company withdrew its FY20 guidance, and said it sees some weakness in COVID-19-impacted industries, but noted those only represent about 15% of its base. Ho sees privileged access management solutions as a "critical component of cybersecurity that continues to see high prioritization," and noted that CyberArk "has actually seen its pipeline increase from late March into the first few weeks of May, suggesting no lack of demand."

ShowHide Related Items >><<
CYBR CyberArk
$97.00 /

-12.68 (-11.56%)

CYBR CyberArk
$97.00 /

-12.68 (-11.56%)

04/08/20 DA Davidson
DA Davidson says Proofpoint, SailPoint have strongest pipelines in sector
03/24/20 Goldman Sachs
Goldman Sachs starts Rapid7, Tenable Holdings at Buy, SailPoint at Sell
03/24/20 Goldman Sachs
CyberArk initiated with a Neutral at Goldman Sachs
03/23/20 Piper Sandler
CyberArk upgraded to Overweight on recent selloff at Piper Sandler
CYBR CyberArk
$97.00 /

-12.68 (-11.56%)

CYBR CyberArk
$97.00 /

-12.68 (-11.56%)

On The Fly
Fly Intel: Pre-market Movers » 09:11
05/13/20
05/13
09:11
05/13/20
09:11
GILD

Gilead

$77.94 /

-2.86 (-3.54%)

, ROKU

Roku

$127.14 /

-5.06 (-3.83%)

, JCP

J.C. Penney

$0.20 /

+0.0447 (+29.06%)

, JD

JD.com

$47.03 /

+0.31 (+0.66%)

, LVS

Las Vegas Sands

$45.97 /

-2.51 (-5.18%)

, MYL

Mylan

$16.21 /

-0.7 (-4.14%)

, UNFI

United Natural Foods

$15.54 /

+2.87 (+22.65%)

, CYBR

CyberArk

$109.65 /

-5.33 (-4.64%)

, INFN

Infinera

$5.81 /

+0.17 (+3.01%)

, ADPT

Adaptive Biotechnologies

$38.10 /

-0.03 (-0.08%)

, NE

Noble Corp.

$0.21 /

+0.0035 (+1.74%)

, BLUE

Bluebird Bio

$56.85 /

-3.37 (-5.60%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
UNFI United Natural Foods
$15.54 /

+2.87 (+22.65%)

ROKU Roku
$127.14 /

-5.06 (-3.83%)

NE Noble Corp.
$0.21 /

+0.0035 (+1.74%)

MYL Mylan
$16.21 /

-0.7 (-4.14%)

LVS Las Vegas Sands
$45.97 /

-2.51 (-5.18%)

JD JD.com
$47.03 /

+0.31 (+0.66%)

JCP J.C. Penney
$0.20 /

+0.0447 (+29.06%)

INFN Infinera
$5.81 /

+0.17 (+3.01%)

GILD Gilead
$77.94 /

-2.86 (-3.54%)

CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

BLUE Bluebird Bio
$56.85 /

-3.37 (-5.60%)

ADPT Adaptive Biotechnologies
$38.10 /

-0.03 (-0.08%)

GILD Gilead
$77.94 /

-2.86 (-3.54%)

05/11/20 RBC Capital
Gilead's U.S. remdesivir supply to be 'severely constrained', says RBC Capital
05/06/20 Goldman Sachs
Goldman says Novo Nordisk NASH data a 'clear positive' for Intercept
05/05/20 Citi
ICER value of Remdesivir at $4,500 supportive of value, says Citi
05/04/20 Benchmark
Regeneron report more about COVID-19 progress than earnings, says Benchmark
ROKU Roku
$127.14 /

-5.06 (-3.83%)

05/08/20 Susquehanna
Roku price target lowered to $145 from $170 at Susquehanna
05/08/20 Loop Capital
Roku price target raised to $90 from $70 at Loop Capital
05/08/20 Wedbush
Roku price target raised to $136 from $86 at Wedbush
04/29/20
Fly Intel: Top five analyst initiations
JCP J.C. Penney
$0.20 /

+0.0447 (+29.06%)

04/16/20 Oppenheimer
Ulta Beauty price target raised to $240 from $220 at Oppenheimer
01/14/20 Oppenheimer
Ulta Beauty price target raised to $310 from $275 at Oppenheimer
11/18/19 Deutsche Bank
Deutsche Bank stays on sidelines despite J.C. Penney's margin gains
07/25/19 Oppenheimer
Ulta Beauty price target raised to $390 from $370 at Oppenheimer
JD JD.com
$47.03 /

+0.31 (+0.66%)

05/13/20 Mizuho
JD.com upgraded to Buy from Neutral at Mizuho
04/14/20 Morgan Stanley
JD.com upgraded to Overweight from Equal Weight at Morgan Stanley
03/17/20 Bernstein
JD.com upgraded to Outperform from Market Perform at Bernstein
03/03/20 Susquehanna
JD.com price target raised to $45 from $35 at Susquehanna
LVS Las Vegas Sands
$45.97 /

-2.51 (-5.18%)

05/06/20 Roth Capital
Las Vegas Sands price target lowered to $52 from $69 at Roth Capital
04/23/20
Fly Intel: Top five analyst upgrades
04/23/20 JPMorgan
JPMorgan upgrades Las Vegas Sands to Overweight, sees entry point
04/23/20 Deutsche Bank
Las Vegas Sands price target raised to $54 from $50 at Deutsche Bank
MYL Mylan
$16.21 /

-0.7 (-4.14%)

03/25/20 Cantor Fitzgerald
Few concerns weighing on Mylan shares today, says Cantor Fitzgerald
02/06/20 BMO Capital
Biogen price target raised to $317 from $297 at BMO Capital
02/05/20 Baird
Biogen price target raised to $290 from $250 at Baird
02/05/20 Mizuho
Biogen's Tecfidera win worth $15-$30 per share to DCF, Mizuho says
UNFI United Natural Foods
$15.54 /

+2.87 (+22.65%)

05/13/20 Wells Fargo
United Natural Foods upgraded to Equal Weight on COVID benefits at Wells Fargo
05/13/20 Wells Fargo
United Natural Foods upgraded to Equal Weight from Underweight at Wells Fargo
03/19/20 Barclays
United Natural Foods upgraded to Equal Weight from Underweight at Barclays
03/18/20 BMO Capital
United Natural Foods upgraded to Market Perform from Underperform at BMO Capital
CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

04/08/20 DA Davidson
DA Davidson says Proofpoint, SailPoint have strongest pipelines in sector
03/24/20 Goldman Sachs
Goldman Sachs starts Rapid7, Tenable Holdings at Buy, SailPoint at Sell
03/24/20 Goldman Sachs
CyberArk initiated with a Neutral at Goldman Sachs
03/23/20 Piper Sandler
CyberArk upgraded to Overweight on recent selloff at Piper Sandler
INFN Infinera
$5.81 /

+0.17 (+3.01%)

05/13/20 Northland
Infinera downgraded to Market Perform with $5 target at Northland
05/13/20 Northland
Infinera downgraded to Market Perform from Outperform at Northland
05/13/20 MKM Partners
Infinera price target lowered to $7.50 from $10.50 at MKM Partners
05/13/20 Northland
Infinera downgraded to Market Perform from Outperform at Northland
ADPT Adaptive Biotechnologies
$38.10 /

-0.03 (-0.08%)

03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
01/09/20 JPMorgan
Danaher, Thermo named JPMorgan's top 2020 picks in Life Science Tools
11/13/19 JPMorgan
Adaptive Biotechnologies still has upside potential despite rally, says JPMorgan
07/23/19
Fly Intel: Top five analyst initiations
NE Noble Corp.
$0.21 /

+0.0035 (+1.74%)

05/13/20 Credit Suisse
Noble Corp. downgraded to Underperform from Neutral at Credit Suisse
04/21/20 RBC Capital
Noble Corp. downgraded to Underperform from Sector Perform at RBC Capital
03/17/20 Capital One
Noble Corp. downgraded to Underweight from Equalweight at Capital One
03/13/20 Wells Fargo
Drillers downgraded at Wells Fargo on recent sell off in commodity prices
BLUE Bluebird Bio
$56.85 /

-3.37 (-5.60%)

05/12/20 RBC Capital
Bluebird Bio initiated with an Outperform at RBC Capital
05/12/20 Oppenheimer
Bluebird Bio price target lowered to $111 from $122 at Oppenheimer
05/11/20 Piper Sandler
Bluebird Bio price target lowered to $70 from $75 at Piper Sandler
03/27/20 BMO Capital
Bluebird Bio price target lowered to $107 from $132 at BMO Capital
UNFI United Natural Foods
$15.54 /

+2.87 (+22.65%)

ROKU Roku
$127.14 /

-5.06 (-3.83%)

NE Noble Corp.
$0.21 /

+0.0035 (+1.74%)

MYL Mylan
$16.21 /

-0.7 (-4.14%)

LVS Las Vegas Sands
$45.97 /

-2.51 (-5.18%)

JD JD.com
$47.03 /

+0.31 (+0.66%)

JCP J.C. Penney
$0.20 /

+0.0447 (+29.06%)

INFN Infinera
$5.81 /

+0.17 (+3.01%)

GILD Gilead
$77.94 /

-2.86 (-3.54%)

CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

BLUE Bluebird Bio
$56.85 /

-3.37 (-5.60%)

ADPT Adaptive Biotechnologies
$38.10 /

-0.03 (-0.08%)

ROKU Roku
$127.14 /

-5.06 (-3.83%)

NE Noble Corp.
$0.21 /

+0.0035 (+1.74%)

MYL Mylan
$16.21 /

-0.7 (-4.14%)

LVS Las Vegas Sands
$45.97 /

-2.51 (-5.18%)

JD JD.com
$47.03 /

+0.31 (+0.66%)

JCP J.C. Penney
$0.20 /

+0.0447 (+29.06%)

GILD Gilead
$77.94 /

-2.86 (-3.54%)

UNFI United Natural Foods
$15.54 /

+2.87 (+22.65%)

ROKU Roku
$127.14 /

-5.06 (-3.83%)

NE Noble Corp.
$0.21 /

+0.0035 (+1.74%)

MYL Mylan
$16.21 /

-0.7 (-4.14%)

LVS Las Vegas Sands
$45.97 /

-2.51 (-5.18%)

JD JD.com
$47.03 /

+0.31 (+0.66%)

JCP J.C. Penney
$0.20 /

+0.0447 (+29.06%)

GILD Gilead
$77.94 /

-2.86 (-3.54%)

CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

UNFI United Natural Foods
$15.54 /

+2.87 (+22.65%)

ROKU Roku
$127.14 /

-5.06 (-3.83%)

MYL Mylan
$16.21 /

-0.7 (-4.14%)

LVS Las Vegas Sands
$45.97 /

-2.51 (-5.18%)

JD JD.com
$47.03 /

+0.31 (+0.66%)

JCP J.C. Penney
$0.20 /

+0.0447 (+29.06%)

INFN Infinera
$5.81 /

+0.17 (+3.01%)

GILD Gilead
$77.94 /

-2.86 (-3.54%)

Hot Stocks
CyberArk acquires Idaptive for $70M in cash » 07:09
05/13/20
05/13
07:09
05/13/20
07:09
CYBR

CyberArk

$109.65 /

-5.33 (-4.64%)

CyberArk announced it has…

CyberArk announced it has acquired Santa Clara, California-based IDaptive Holdings. Together, CyberArk and Idaptive will deliver the industry's only modern identity platform with a security-first approach. The total purchase price for the acquisition of Idaptive was $70M in cash consideration.

ShowHide Related Items >><<
CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

04/08/20 DA Davidson
DA Davidson says Proofpoint, SailPoint have strongest pipelines in sector
03/24/20 Goldman Sachs
Goldman Sachs starts Rapid7, Tenable Holdings at Buy, SailPoint at Sell
03/24/20 Goldman Sachs
CyberArk initiated with a Neutral at Goldman Sachs
03/23/20 Piper Sandler
CyberArk upgraded to Overweight on recent selloff at Piper Sandler
CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

Earnings
CyberArk withdraws FY20 guidance due to COVID-19 » 07:08
05/13/20
05/13
07:08
05/13/20
07:08
CYBR

CyberArk

$109.65 /

-5.33 (-4.64%)

Given the uncertainty…

Given the uncertainty created by the COVID-19 pandemic as well as its impact on the overall economy, our business, our customers and our partners, we are withdrawing our full year 2020 guidance for total revenue, non-GAAP operating income, and non-GAAP EPS that we provided on February 12.

ShowHide Related Items >><<
CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

04/08/20 DA Davidson
DA Davidson says Proofpoint, SailPoint have strongest pipelines in sector
03/24/20 Goldman Sachs
Goldman Sachs starts Rapid7, Tenable Holdings at Buy, SailPoint at Sell
03/24/20 Goldman Sachs
CyberArk initiated with a Neutral at Goldman Sachs
03/23/20 Piper Sandler
CyberArk upgraded to Overweight on recent selloff at Piper Sandler
CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

Earnings
CyberArk reports Q1 EPS 50c, consensus 36c » 07:07
05/13/20
05/13
07:07
05/13/20
07:07
CYBR

CyberArk

$109.65 /

-5.33 (-4.64%)

Reports Q1 revenue…

Reports Q1 revenue $106.8M, consensus $105.63M. "The health and well-being of our global community of employees, customers and partners continues to be our first priority," said Udi Mokady, CyberArk Chairman and CEO. "We were pleased to deliver results in line with or exceeding all guided metrics for the first quarter. Privileged Access Management (PAM) is even more critical today with attackers exploiting the sudden and dramatic change in enterprise IT created by remote work environments. In this higher threat environment, our level of engagement with customers has increased as they look to better secure their extended enterprise by expanding their PAM programs. Given our leadership position in PAM, our team's extensive experience during prior market downturns as well as our ongoing commitment to innovation and customer satisfaction, we believe that we will emerge from the COVID-19 pandemic stronger than before. We are also pleased with today's acquisition of Idaptive, which positions us as the only modern identity security platform, adds another SaaS offering to our portfolio, and expands our Total Addressable Market."

ShowHide Related Items >><<
CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

04/08/20 DA Davidson
DA Davidson says Proofpoint, SailPoint have strongest pipelines in sector
03/24/20 Goldman Sachs
Goldman Sachs starts Rapid7, Tenable Holdings at Buy, SailPoint at Sell
03/24/20 Goldman Sachs
CyberArk initiated with a Neutral at Goldman Sachs
03/23/20 Piper Sandler
CyberArk upgraded to Overweight on recent selloff at Piper Sandler
CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

CYBR CyberArk
$109.65 /

-5.33 (-4.64%)

Over a month ago
Recommendations
DA Davidson says Proofpoint, SailPoint have strongest pipelines in sector » 18:55
04/08/20
04/08
18:55
04/08/20
18:55
PFPT

Proofpoint

$114.08 /

+5.84 (+5.40%)

, FTNT

Fortinet

$109.14 /

+2.45 (+2.30%)

, SAIL

SailPoint

$15.40 /

+1.16 (+8.15%)

, CYBR

CyberArk

$86.13 /

+2.88 (+3.46%)

DA Davidson analyst…

DA Davidson analyst Andrew Nowinski said that he conducted a Q1 Security Reseller survey, collecting feedback from 30 resellers and distributors across North America, Europe, and APAC. Nowinski said that Proofpoint (PFPT) had the "top" results in the survey, likely driven by a boost in phishing attacks amid the coronavirus outbreak, and that Fortinet's (FTNT) results were "OK," though it was a downtick from the previous quarter. The analyst said that SailPoint (SAIL) had net negative results, but they were still "far better" than he anticipated. Nowinski also noted "surprisingly weak" results for CyberArk (CYBR), which "significantly" downticked from Q4, likely attributable to COVID-19. Looking ahead to Q2, the analyst said the Proofpoint and SailPoint had the strongest pipelines. Nowinski has Neutral ratings on CyberArk, Fortinet, and SailPoint, and a Buy rating on Proofpoint.

ShowHide Related Items >><<
PFPT Proofpoint
$114.08 /

+5.84 (+5.40%)

03/27/20 BTIG
Proofpoint assumed with a Buy at BTIG
03/24/20 Goldman Sachs
Goldman Sachs starts Rapid7, Tenable Holdings at Buy, SailPoint at Sell
03/24/20 Goldman Sachs
Proofpoint initiated with a Neutral at Goldman Sachs
03/04/20 First Analysis
Proofpoint upgraded to Strong Buy from Outperform at First Analysis
FTNT Fortinet
$109.14 /

+2.45 (+2.30%)

04/03/20 Raymond James
Fortinet price target lowered to $115 from $136 at Raymond James
03/27/20 BTIG
Fortinet initiated with a Neutral at BTIG
03/17/20
Fly Intel: Top five analyst downgrades
03/17/20 DA Davidson
Fortinet downgraded to Neutral from Buy at DA Davidson
SAIL SailPoint
$15.40 /

+1.16 (+8.15%)

03/24/20 Goldman Sachs
SailPoint initiated with a Sell at Goldman Sachs
03/12/20 Wedbush
Apple, Microsoft among tech names to own through COVID-19 slowdown, says Wedbush
01/14/20
SailPoint initiated with a Neutral at DA Davidson
CYBR CyberArk
$86.13 /

+2.88 (+3.46%)

03/24/20 Goldman Sachs
CyberArk initiated with a Neutral at Goldman Sachs
03/23/20 Piper Sandler
CyberArk upgraded to Overweight on recent selloff at Piper Sandler
03/22/20 Piper Sandler
CyberArk upgraded to Overweight from Neutral at Piper Sandler

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.